Plain-English translation of NCT06976073 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →This trial is testing a new imaging device called SFDI (Spatial Frequency Domain Imaging) — a camera that takes detailed pictures of your skin without touching it. The device measures blood oxygen levels, blood flow, and other properties in your skin to help doctors better assess your risk for heart disease, diabetes, and circulation problems. The study will enroll about 8,000 people from primary care clinics, including those with diabetes, circulation problems, or heart disease risk.
Current methods for assessing heart disease risk and circulation problems are limited or invasive. This trial exists to see whether a simple, non-invasive skin imaging tool can accurately measure blood flow and tissue health to catch circulation and heart problems earlier and help doctors make better decisions about your care.
You likely qualify if…
You likely don't qualify if…
At your initial visit, you will have a quick, painless scan with the imaging device over your skin — no needles or touching required. Depending on your health risk level, you may be asked to come back for an extended exam that includes additional scans and a brief blood flow test. Some participants may be invited to return for yearly follow-up scans to see how their skin health and circulation change over time. The whole process is non-invasive and takes place during routine primary care visits.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
Sweden